Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Luc Staner, Philippe Danjou & Remy Luthringer. (2012) A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia. Expert Review of Neurotherapeutics 12:2, pages 141-153.
Read now
Read now
Yolande Lucire & Christopher Crotty. (2011) Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family. Pharmacogenomics and Personalized Medicine 4, pages 65-81.
Read now
Read now
Cynthia Kirkwood, Jason Neill & Ericka Breden. (2007) Zolpidem modified-release in insomnia. Neuropsychiatric Disease and Treatment 3:5, pages 521-526.
Read now
Read now
GinaA. Mollet, DavidW. Harrison, RobertP. Walters & PaulS. Foster. (2007) Asymmetry in the emotional content of lateralised multimodal hallucinations following right thalamic stroke. Cognitive Neuropsychiatry 12:5, pages 422-436.
Read now
Read now
Ming‐Jun Tsai, Yaw‐Bin Huang & Pao‐Chu Wu. (2003) A Novel Clinical Pattern of Visual Hallucination After Zolpidem Use. Journal of Toxicology: Clinical Toxicology 41:6, pages 869-872.
Read now
Read now
. (2002) Zolpidem, vascular headache, and hallucinations in an adolescent. Australian and New Zealand Journal of Psychiatry 36:3, pages 425-426.
Read now
Read now
Articles from other publishers (34)
Laura Palagini & Carlotta Bianchini. (2022) Pharmacotherapeutic management of insomnia and effects on sleep processes, neural plasticity, and brain systems modulating stress: A narrative review. Frontiers in Neuroscience 16.
Crossref
Crossref
Agata M. Grzegorzewska, Jerzy J. Landowski & Wiesław J. Cubała. (2020) Clinical considerations of sleep related amnestic behaviours associated with zolpidem. Pharmacotherapy in Psychiatry and Neurology 36:1, pages 23-31.
Crossref
Crossref
Joseph Westermeyer & Tegan M. Carr. (2020) Zolpidem-Associated Consequences. Journal of Nervous & Mental Disease 208:1, pages 28-32.
Crossref
Crossref
Vijayabharathi Ekambaram & Britta Klara Ostermeyer. 2019. Comorbid Sleep and Psychiatric Disorders. Comorbid Sleep and Psychiatric Disorders
137
148
.
Karen Isabel Birnie, Robert Stewart & Anna Kolliakou. (2018) Recorded atypical hallucinations in psychotic and affective disorders and associations with non-benzodiazepine hypnotic use: the South London and Maudsley Case Register. BMJ Open 8:9, pages e025216.
Crossref
Crossref
Dushad Ram, Najla Eiman & Basavana Gowdappa. (2015) Multimodal Hallucination (Audio-visual, Kinaesthetic and Scenic) Associated with the Use of Zolpidem. Clinical Psychopharmacology and Neuroscience 13:2, pages 215-217.
Crossref
Crossref
Sameh Mortaz Hejri, Mehrdad Faizi & Mohammad Babaeian. (2013) Zolpidem-induced suicide attempt: a case report. DARU Journal of Pharmaceutical Sciences 21:1.
Crossref
Crossref
Naren Gunja. (2013) The Clinical and Forensic Toxicology of Z-drugs. Journal of Medical Toxicology 9:2, pages 155-162.
Crossref
Crossref
Anna Ivanenko & Sachin Relia. 2013. Parasomnias. Parasomnias
207
220
.
Shannon Kinnan, Frederick Petty & Daniel R. Wilson. (2011) Zolpidem-Induced Mania in a Patient with Schizoaffective Disorder. Psychosomatics 52:5, pages 493-494.
Crossref
Crossref
Grzegorz R. Juszczak. (2011) Desensitization of GABAergic receptors as a mechanism of zolpidem-induced somnambulism. Medical Hypotheses 77:2, pages 230-233.
Crossref
Crossref
Neven A Knuistingh, PLBJ Lucassen, K Bonsema, H Teunissen, MM Verduijn & M Bouma. 2011. NHG- Standaarden voor de huisarts 2011. NHG- Standaarden voor de huisarts 2011
953
974
.
T. Javelot, H. Javelot, A. Baratta, L. Weiner, M. Messaoudi & P. Lemoine. (2010) Troubles psychotiques aigus liés au bupropion : revue de la littérature. L'Encéphale 36:6, pages 461-471.
Crossref
Crossref
Frank Barile. 2010. Clinical Toxicology. Clinical Toxicology
138
149
.
Luc Staner, Françoise Cornette, Sarah Otmani, Jean -François Nedelec & Philippe Danjou. 2010. GABA and Sleep. GABA and Sleep
383
411
.
Timothy P. Rohrig, Lydia A. Harryman & Melissa C. Norton. 2010. Clinical Applications of Mass Spectrometry. Clinical Applications of Mass Spectrometry
519
526
.
J.M. MontiD. Warren SpenceS.R. Pandi-PerumalSalomon Z. LangerR. Hardeland. (2009) Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release. Clinical Medicine. Therapeutics 1, pages CMT.S2040.
Crossref
Crossref
A Knuistingh Neven, P L B J Lucassen, K Bonsema, H Teunissen, M M Verduijn & M Bouma. 2009. NHG-Standaarden voor de huisarts 2009. NHG-Standaarden voor de huisarts 2009
558
579
.
Sanne de Haas, Jasper Dingemanse, Petra Hoever, Adam Cohen & Joop van Gerven. (2007) Pseudohallucinations After Zolpidem Intake. Journal of Clinical Psychopharmacology 27:6, pages 728-730.
Crossref
Crossref
Junji Takeshita, Diane Thompson & Stephen E. Nicolson. 2010. The Spectrum of Psychotic Disorders. The Spectrum of Psychotic Disorders
406
452
.
JOHN G. BENITEZ, LINDA G. ALLISON & SHARON TERNULLO. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
659
670
.
Christopher L Lange. (2005) MEDICATION-ASSOCIATED SOMNAMBULISM. Journal of the American Academy of Child & Adolescent Psychiatry 44:3, pages 211-212.
Crossref
Crossref
Iacopo Cancelli, Gabriella Marcon & Matteo Balestrieri. (2004) Factors associated with complex visual hallucinations during antidepressant treatment. Human Psychopharmacology: Clinical and Experimental 19:8, pages 577-584.
Crossref
Crossref
Sirpa A. Tavakoli & Ondria C. Gleason. (2003) Seizures Associated With Venlafaxine, Methylphenidate, and Zolpidem. Psychosomatics 44:3, pages 262-264.
Crossref
Crossref
L. Hosák & J. Libiger. (2020) Medicamentos antiepilépticos en la esquizofrenia: una revisión. European psychiatry (Ed. Española) 10:4, pages 217-224.
Crossref
Crossref
Mario Giovanni Terzano, Mariano Rossi, Vincenzo Palomba, Arianna Smerieri & Liborio Parrino. (2003) New Drugs for Insomnia. Drug Safety 26:4, pages 261-282.
Crossref
Crossref
N. J. Langford, U. Martin, M. Ruprah & R. E. Ferner. (2002) Alternative venlafaxine kinetics in overdose. Journal of Clinical Pharmacy and Therapeutics 27:6, pages 465-467.
Crossref
Crossref
L. Hosák & J. Libiger. (2020) Antiepileptic drugs in schizophrenia: a review. European Psychiatry 17:7, pages 371-378.
Crossref
Crossref
G. Laux, A. Eckert, W. E. Müller, U. Breyer-Pfaff, S. Kasper, M. Riedel, N. Müller, H. J. Möller, C. Hiemke, C. Schöchlin & R. R. Engel. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
223
363
.
. 2001. Dreisbach's Handbook of Poisoning. Dreisbach's Handbook of Poisoning
390
421
.
Ion Anghelescu, Christoph Klawe, Hubertus Himmerich & Armin Szegedi. (2001) Topiramate in Venlafaxine-Induced Visual Hallucinations in an Obese Patient With a Posterior Cerebral Artery Infarction. Journal of Clinical Psychopharmacology 21:4, pages 462-464.
Crossref
Crossref
Pierre Voirol, Pierre-François Hodel, Daniele Zullino & Pierre Baumann. (2000) Serotonin Syndrome After Small Doses of Citalopram or Sertraline. Journal of Clinical Psychopharmacology 20:6, pages 713-714.
Crossref
Crossref
Kristin J. Holm & Karen L. Goa. (2000) Zolpidem. Drugs 59:4, pages 865-889.
Crossref
Crossref
Laura C. Toner, Belen M. Tsambiras, Glenn Catalano, Maria C. Catalano & David S. Cooper. (2000) Central Nervous System Side Effects Associated with Zolpidem Treatment. Clinical Neuropharmacology 23:1, pages 54-58.
Crossref
Crossref